BDBM275069 US10221195, Example 11::US9879032, Example 11

SMILES: COc1ccc(CO)cc1S(=O)(=O)Nc1cnc2OCCNC(=O)c2c1

InChI Key: InChIKey=RJPIPABCNGQDLI-UHFFFAOYSA-N

Data: 2 IC50

Find this compound or compounds like it in BindingDB or PDB:

Substructure Similarity at least:  must be >=0.5 Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 275069   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Alkaline phosphatase, tissue-nonspecific isozyme (Homo sapiens (Human))	BDBM275069 (US10221195, Example 11 | US9879032, Example 11) Show SMILES COc1ccc(CO)cc1S(=O)(=O)Nc1cnc2OCCNC(=O)c2c1 Show InChI InChI=1S/C16H17N3O6S/c1-24-13-3-2-10(9-20)6-14(13)26(22,23)19-11-7-12-15(21)17-4-5-25-16(12)18-8-11/h2-3,6-8,19-20H,4-5,9H2,1H3,(H,17,21)	KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.80	n/a	n/a	n/a	n/a	n/a	n/a
Daiichi Sankyo Company, Limited; Sanford Burnham Prebys Medical Discovery Institute US Patent					Assay Description COS1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (Inv...				US Patent US10221195 (2019) BindingDB Entry DOI: 10.7270/Q2QZ2D83
					More data for this Ligand-Target Pair
Alkaline phosphatase, tissue-nonspecific isozyme (Homo sapiens (Human))	BDBM275069 (US10221195, Example 11 | US9879032, Example 11) Show SMILES COc1ccc(CO)cc1S(=O)(=O)Nc1cnc2OCCNC(=O)c2c1 Show InChI InChI=1S/C16H17N3O6S/c1-24-13-3-2-10(9-20)6-14(13)26(22,23)19-11-7-12-15(21)17-4-5-25-16(12)18-8-11/h2-3,6-8,19-20H,4-5,9H2,1H3,(H,17,21)	KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	4.80	n/a	n/a	n/a	n/a	n/a	25
Daiichi Sankyo Company, Limited; Sandford Burnham Prebys Medical Discovery Institute US Patent					Assay Description COS 1 cells (DS Pharma Biomedical Co., Ltd.) were transfected with human TNAP (OriGene Technologies, Inc.) using Lipofectamine LTX & Plus reagent (In...				US Patent US9879032 (2018) BindingDB Entry DOI: 10.7270/Q2F76FKB
					More data for this Ligand-Target Pair